Venus Remedies has received marketing authorization for its antibiotic drug Meropenem from Australian regulator TGA. The company has also tied-up with Lupin to market this drug in Australia.The company planning to roll out the drug by the third quarter of 2014.
Meropenem is an off-patent antibacterial agent of the Carbapenem class of antibiotics that caters to diseases with a broad range of serious infections caused by single or multiple susceptible bacteria in both adults and children.
Venus Remedies is a pharmaceutical manufacturing company. The company provides formulations in area of antibiotics and oncological therapeutics. The company has two manufacturing facilities located in India and Germany. It manufactures Oncological and Cefelosporine Injectable products.
|
Monday, 19 May 2014
Venus Remedies gets nod to sell Meropenem in Australia
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment